Anna Chen, Jennifer Ann Woyach, John Francis Seymour, Danielle M. Brander, Deborah Marie Stephens, Neil E. Kay, Fenlai Tan, Yi Chen, Stephen Patrick Anthony, Kewei Shang, Yue Shen, Yejiang Lou, John C. Byrd. "ROCKET-CLL: A randomized, open-label, multicenter, phase 3 study of rocbrutinib (LP-168) versus pirtobrutinib in covalent BTK inhibitor (cBTKi) in pretreated relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps7100